Evidence map›Paper›PMID 39920259›Full record

ArticleScientific reports2025

Prediction of inhibitory peptides against E.coli with desired MIC value.

Nisha Bajiya, Nishant Kumar, Gajendra P S Raghava

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nisha BajiyaDepartment of Computational Biology, Indraprastha Institute of Information Technology, Delhi, Okhla Industrial Estate, Phase III (Near Govind Puri Metro Station), A-302 (R&D Block), New Delhi, 110020, India.ORCID 0000-0002-5075-5386
Nishant KumarDepartment of Computational Biology, Indraprastha Institute of Information Technology, Delhi, Okhla Industrial Estate, Phase III (Near Govind Puri Metro Station), A-302 (R&D Block), New Delhi, 110020, India.ORCID 0000-0001-7781-9602
Gajendra P S RaghavaDepartment of Computational Biology, Indraprastha Institute of Information Technology, Delhi, Okhla Industrial Estate, Phase III (Near Govind Puri Metro Station), A-302 (R&D Block), New Delhi, 110020, India. raghava@iiitd.ac.in.ORCID 0000-0002-8902-2876

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/PR40158/BTIS/137/24/2021
6 · The paper itself

Abstract

In the past, several methods have been developed for predicting antibacterial and antimicrobial peptides, but only limited attempts have been made to predict their minimum inhibitory concentration (MIC) values. In this study, we developed predictive models for MIC values of antibacterial peptides against Escherichia coli (E. coli), comprised of 3143 peptides for training and 786 peptides for validation, with experimentally determined MIC values. We found that the Composition Enhanced Transition and Distribution (CeTD) attributes significantly correlate with MIC values. Initially, we attempted to estimate MIC using BLAST similarity searches but found them inadequate. Subsequently, we employed machine learning regression models that integrated various features, including peptide composition, binary profiles and embeddings from large language models. Feature selection techniques, particularly mRMR, were utilized to refine our model inputs. Our Random Forest regressor built using default parameters achieved a correlation coefficient (R) of 0.78, R

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesEscherichia coliPeptidesMachine LearningMicrobial Sensitivity TestsAnti-Bacterial AgentsAntimicrobial PeptidesPeptidesEscherichia coliInhibitory peptidesMachine learningMinimum Inhibitory concentrationPeptide designRegression models

Identifiers

PMID39920259
PMCPMC11805985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.